Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Essentials of Medical Pharmacology
2008628 citationsKD TripathiJaypee Brothers Medical Publishers (P) Ltd. eBooksprofile →
Essentials of Medical Pharmacology
2013410 citationsKD TripathiJaypee Brothers Medical Publishers (P) Ltd. eBooksprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of KD Tripathi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by KD Tripathi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites KD Tripathi more than expected).
This network shows the impact of papers produced by KD Tripathi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by KD Tripathi. The network helps show where KD Tripathi may publish in the future.
Co-authorship network of co-authors of KD Tripathi
This figure shows the co-authorship network connecting the top 25 collaborators of KD Tripathi.
A scholar is included among the top collaborators of KD Tripathi based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with KD Tripathi. KD Tripathi is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Tripathi, KD. (2004). MCQs in Pharmacology. Jaypee Brothers Medical Publishers (P) Ltd. eBooks.1 indexed citations
9.
Bhatia, Ashima, KD Tripathi, & Manoj K. Sharma. (2004). Efficacy & tolerability of ondansetron compared to metoclopramide in dose dependent cisplatin-induced delayed emesis.. PubMed. 120(3). 183–93.2 indexed citations
10.
Singh, Amit, et al.. (2004). Spectrum of renal disease in malaria.. PubMed. 102(3). 143, 146, 148 passim–143, 146, 148 passim.23 indexed citations
11.
Bhatia, Ashima, KD Tripathi, & Manoj K. Sharma. (2003). Comparison of ondansetron with metoclopramide in prevention of acute emesis associated with low dose & high dose cisplatin chemotherapy.. PubMed. 118. 33–41.4 indexed citations
12.
Tripathi, KD, et al.. (2002). Medialization in management of unstable intertrochanteric fractures. Indian Journal of Orthopaedics. 36(2). 10.
13.
Tripathi, KD, et al.. (2000). Association of drug levels & pharmacokinetics of carbamazepine with seizure control.. PubMed. 112. 218–23.1 indexed citations
14.
Valecha, Neena & KD Tripathi. (1997). Artemisinin: current status in malaria. Indian Journal of Pharmacology. 29(2). 71.10 indexed citations
15.
Tripathi, KD, Aditi Sharma, Neena Valecha, & Sudipta Biswas. (1993). In vitro activity of fluoroquinolones against chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum.. PubMed. 30(2). 67–73.14 indexed citations
Adithan, C, et al.. (1992). Pharmacokinetics of ciprofloxacin - limitation to salivary and urinary sampling. Indian Journal of Pharmacology. 24(1). 25.4 indexed citations
18.
Valecha, Neena, et al.. (1990). Single dose pharmacokinetics of lithium and prediction of maintenance dose in manic depressive patients.. PubMed. 92. 409–16.4 indexed citations
19.
Prakash, Jyoti, et al.. (1988). Amyloid nephropathy in ankylosing spondylitis.. PubMed. 86(1). 3–5.3 indexed citations
20.
Tripathi, KD, et al.. (1978). Effect of morphine on electroshock seizures in rat.. PubMed. 16(9). 992–3.3 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.